BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Cefpodoxime Proxetil

A prodrug of its active metabolite CEFPODOXIME.

285+ PubMed studies analyzed · 47 RCTs · Evidence Score: 50

Research Domains

Cefpodoxime Proxetil has been studied across 9 research domains including 🫁 Respiratory, 🧠 Focus & Attention, 🦠 Gut & Microbiome, ✨ Skin & Hair, 🫘 Kidney. The primary research focus is 🫁 Respiratory with 12% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Cefpodoxime Proxetil, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Clobetasol
3 shared targets
Allylestrenol
2 shared targets
Metipranolol
2 shared targets
onapristone
2 shared targets
enzalutamide
2 shared targets
Epitestosterone
2 shared targets
pyrrolnitrin
3 shared targets
metribolone
2 shared targets
Fludrocortisone
3 shared targets
auricularum
2 shared targets
Loading evidence profile...

This evidence profile for Cefpodoxime Proxetil is generated deterministically from 285 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.